The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASEI.L Regulatory News (ASEI)

  • There is currently no data for ASEI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Share Buyback Authority

8 Sep 2021 17:09

RNS Number : 1743L
Aberdeen Standard Equity Income Tst
08 September 2021
 

ABERDEEN STANDARD EQUITY INCOME TRUST PLC (the "Company")

Legal Entity Identifier (LEI): 21380015XPT7BZISSQ74

 

Share buy-back authority

 

8 September 2021

 

Aberdeen Standard Equity Income Trust plc (the "Company") is amending its disclosure policy to include on a regulatory information services ("RIS") details of its share buyback powers which it renews annually. It is expected similar announcements will be made every time the share buyback authority is renewed.

 

The Company announces that it has authority to repurchase a maximum of 7,244,361 of its ordinary shares (being its outstanding shareholder authority). Such authority lasts until conclusion of the next annual general meeting ("AGM") of the Company or, if earlier, the expiry of 15 months from 05 February 2021, being the date of the last AGM, unless the authority is renewed at any other general meeting prior to such time (but the Company may make a contract to purchase shares prior to such expiry which will be executed wholly or partly after such expiry or a purchase pursuant to any such contract). The buyback may be funded from the Company's resources (including cash, portfolio sales and borrowing facilities). The maximum price that may be paid for a share in accordance with the authority is the higher of (a) 5% above the average of the mid-market values of the shares for the 5 business days before the purchase is made and (b) the higher of the price of the last independent trade in the shares and the highest then current independent bid for the shares on the London stock Exchange. No maximum aggregate consideration payable for all shares purchased under the authority has been determined by the Company. The Company is unable to pay a price for any shares pursuant to the buy-back which would equate to the net asset value or a premium on the net asset value.

 

The Company has appointed J.P. Morgan Securities plc to act as its broker in respect of any buybacks.

 

The buy-backs will be undertaken pursuant the Company's discount management policy.

 

This arrangement is in accordance with Chapter 12 of the FCA Listing Rules and the Company's general authority to repurchase shares.

 

Aberdeen Asset Management PLC

Company Secretary

0131 372 2200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSSMFMAEFSESU
Date   Source Headline
10th Feb 202211:18 amRNSNet Asset Value(s)
9th Feb 202211:10 amRNSNet Asset Value(s)
8th Feb 202211:19 amRNSNet Asset Value(s)
7th Feb 20221:22 pmRNSGearing disclosure
7th Feb 202212:20 pmRNSNet Asset Value(s)
7th Feb 202210:40 amRNSMonth End Net Asset Value(s)
4th Feb 20222:50 pmRNSNet Asset Value(s)
4th Feb 202212:59 pmRNSDividend Declaration
4th Feb 202212:51 pmRNSResult of AGM
3rd Feb 202211:19 amRNSNet Asset Value(s)
2nd Feb 202212:43 pmRNSNet Asset Value(s)
31st Jan 20223:45 pmRNSGearing disclosure
31st Jan 202212:50 pmRNSNet Asset Value(s)
28th Jan 202212:17 pmRNSNet Asset Value(s)
27th Jan 202211:29 amRNSNet Asset Value(s)
26th Jan 202211:52 amRNSNet Asset Value(s)
25th Jan 202211:52 amRNSNet Asset Value(s)
24th Jan 20222:51 pmRNSGearing disclosure
24th Jan 202211:39 amRNSNet Asset Value(s)
21st Jan 20221:18 pmRNSNet Asset Value(s)
20th Jan 202211:58 amRNSNet Asset Value(s)
19th Jan 202211:42 amRNSNet Asset Value(s)
18th Jan 202212:22 pmRNSNet Asset Value(s)
17th Jan 20224:27 pmRNSGearing disclosure
17th Jan 202212:13 pmRNSNet Asset Value(s)
17th Jan 202211:35 amRNSPortfolio disclosure
14th Jan 202210:25 amRNSNet Asset Value(s)
13th Jan 202211:36 amRNSNet Asset Value(s)
12th Jan 202212:08 pmRNSNet Asset Value(s)
11th Jan 202212:04 pmRNSNet Asset Value(s)
11th Jan 202210:38 amRNSMonth End Net Asset Value(s)
10th Jan 20221:20 pmRNSGearing disclosure
10th Jan 202211:23 amRNSNet Asset Value(s)
7th Jan 202210:24 amRNSNet Asset Value(s)
6th Jan 202210:58 amRNSNet Asset Value(s)
5th Jan 20225:17 pmRNSQuarterly disclosure
5th Jan 202212:09 pmRNSNet Asset Value(s)
4th Jan 20224:30 pmRNSGearing disclosure
31st Dec 202112:22 pmRNSNet Asset Value(s)
30th Dec 202111:31 amRNSNet Asset Value(s)
29th Dec 20213:19 pmRNSGearing disclosure
29th Dec 202111:29 amRNSNet Asset Value(s)
24th Dec 202111:20 amRNSNet Asset Value(s)
23rd Dec 202112:49 pmRNSNet Asset Value(s)
23rd Dec 202112:38 pmRNSDoc re. Annual Report
22nd Dec 202111:49 amRNSNet Asset Value(s)
21st Dec 202111:42 amRNSNet Asset Value(s)
20th Dec 20212:37 pmRNSGearing disclosure
20th Dec 202112:07 pmRNSNet Asset Value(s)
17th Dec 202112:32 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.